The patient described in the preceding questions has a positive H. pylori antibody blood test. She is compliant with the medical regimen you prescribe. Although her symptoms initially respond, she returns to see you six months later with the same symptoms. Which of the following statements is correct?
- A. She is at high risk for reinfection with H. pylori.
- B. A positive serum IgG indicates that eradication of H. pylori was unsuccessful.
- C. The urease breath test is an ideal test to document failure of eradication.
- D. Dyspepsia usually improves with H. pylori eradication.
Correct Answer: C
Rationale: Step 1: The patient has a positive H. pylori antibody blood test, indicating exposure to the bacteria.
Step 2: Compliance with medical regimen suggests treatment for H. pylori infection.
Step 3: Persistence of symptoms after treatment indicates possible treatment failure.
Step 4: The urease breath test is ideal for detecting treatment failure as it directly measures the presence of H. pylori.
Step 5: Therefore, choice C is correct as it identifies the appropriate test for confirming eradication failure.
Summary:
- Choice A is incorrect as reinfection risk is not the immediate concern.
- Choice B is incorrect as a positive serum IgG doesn't definitively indicate eradication failure.
- Choice D is incorrect as not all dyspepsia cases improve with H. pylori eradication.
You may also like to solve these questions
A 65-year-old white female with a history of arthritis, congestive heart failure, and osteoporosis complains of odynophagia for two weeks. A barium swallow shows a moderate-sized crater just above the gastroesophageal junction. What is the least likely contributor to this condition?
- A. NSAIDs
- B. Alendronate
- C. Iron sulfate
- D. Calcium channel blocker
Correct Answer: D
Rationale: The correct answer is D: Calcium channel blocker. Odynophagia is often associated with esophageal ulcers, which can be exacerbated by NSAIDs (A) due to their effect on the gastric mucosa. Alendronate (B) is a bisphosphonate used to treat osteoporosis and can cause esophagitis. Iron sulfate (C) can also irritate the esophagus. However, calcium channel blockers (D) are least likely to contribute to esophageal ulcers or odynophagia as they do not directly affect the esophagus or increase the risk of ulcers.
A 50-year-old man presents with progressive jaundice, dark urine, and pruritus. Imaging reveals a mass in the head of the pancreas. What is the most likely diagnosis?
- A. Pancreatic cancer
- B. Chronic pancreatitis
- C. Gallstones
- D. Primary sclerosing cholangitis
Correct Answer: A
Rationale: The most likely diagnosis for a 50-year-old man with jaundice, dark urine, pruritus, and a mass in the head of the pancreas is pancreatic cancer. Pancreatic cancer commonly presents with obstructive jaundice due to compression of the common bile duct by the tumor in the head of the pancreas. This leads to dark urine (due to increased bilirubin) and pruritus. Chronic pancreatitis typically presents with recurrent abdominal pain, not progressive jaundice. Gallstones can cause obstructive jaundice but are not associated with a mass in the pancreas. Primary sclerosing cholangitis presents with jaundice, but it typically involves intrahepatic and extrahepatic bile ducts, not the pancreas.
A 56-year-old woman with rheumatoid arthritis has severe joint pain and swelling in her hands. She has a history of peptic ulcer disease five years ago but presently has no GI symptoms. You elect to start her on an NSAID. Which of the following is correct?
- A. Proton-pump inhibitors and H2-blockers are equally effective in prophylaxis against NSAID-related GI toxicity.
- B. Misoprostol is superior to an H2-blocker in prophylaxis against NSAID-related GI toxicity.
- C. Sucralfate is not the drug of choice for prophylaxis in this patient.
- D. H. pylori infection can alter the risk for an NSAID-induced ulcer.
Correct Answer: B
Rationale: Step 1: Misoprostol is a prostaglandin analog that helps protect the gastric mucosa by increasing mucus production. This mechanism of action makes it effective in preventing NSAID-related GI toxicity.
Step 2: H2-blockers (Choice A) and PPIs are not as effective as misoprostol in preventing NSAID-related GI toxicity.
Step 3: Sucralfate (Choice C) is not as effective as misoprostol in preventing NSAID-related GI toxicity due to its different mechanism of action.
Step 4: H. pylori infection (Choice D) can increase the risk of NSAID-induced ulcers but is not directly related to the prophylactic treatment with misoprostol.
A 60-year-old woman presents with fatigue, pruritus, and jaundice. Laboratory tests reveal elevated bilirubin and alkaline phosphatase levels. What is the most likely diagnosis?
- A. Hepatitis C
- B. Primary biliary cirrhosis
- C. Hemochromatosis
- D. Wilson's disease
Correct Answer: B
Rationale: The most likely diagnosis is B: Primary biliary cirrhosis. This condition commonly presents with fatigue, pruritus, jaundice, elevated bilirubin, and alkaline phosphatase levels in older women. Primary biliary cirrhosis is an autoimmune liver disease that leads to destruction of bile ducts. The other choices are less likely because Hepatitis C typically presents with acute symptoms, Hemochromatosis presents with iron overload symptoms, and Wilson's disease presents with copper accumulation symptoms, which do not match the patient's clinical presentation.
A 65-year-old woman presents with difficulty swallowing, weight loss, and a history of long-standing heartburn. She has been on proton-pump inhibitors for years, but her symptoms have worsened. What is the most likely diagnosis?
- A. Peptic stricture
- B. Esophageal cancer
- C. Achalasia
- D. Esophageal spasm
Correct Answer: B
Rationale: The correct answer is B: Esophageal cancer. Given the patient's age, symptoms of difficulty swallowing and weight loss, along with a history of chronic heartburn not responding to proton-pump inhibitors, esophageal cancer is the most likely diagnosis. Esophageal cancer commonly presents with dysphagia, weight loss, and a history of chronic reflux. Peptic stricture (A) typically presents with dysphagia but is less likely given the worsening symptoms despite treatment. Achalasia (C) presents with dysphagia and regurgitation, but not typically with weight loss. Esophageal spasm (D) presents with chest pain and dysphagia, but not typically with weight loss or chronic heartburn.